skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 732,877  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: ProQuest Central remove subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Material Type:
Article
Add to My Research

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.575-586 [Peer Reviewed Journal]

The Author(s) 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4085-4 ;PMID: 28008555 ;CODEN: BCTRD6

Full text available

2
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Material Type:
Article
Add to My Research

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.465-470 [Peer Reviewed Journal]

Springer Science+Business Media New York 2012 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Springer Science+Business Media New York 2013 ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-012-2355-3 ;PMID: 23224235 ;CODEN: BCTRD6

Full text available

3
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
Material Type:
Article
Add to My Research

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

British journal of cancer, 2019-12, Vol.121 (12), p.991-1000 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0619-y ;PMID: 31719684

Full text available

4
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30313-3 ;PMID: 28526538

Full text available

5
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer
Material Type:
Article
Add to My Research

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

Breast cancer research and treatment, 2018-05, Vol.169 (1), p.105-113 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4661-x ;PMID: 29335925

Full text available

6
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30312-1 ;PMID: 28526536

Full text available

7
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Material Type:
Article
Add to My Research

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

The lancet oncology, 2012-04, Vol.13 (4), p.e148-e160 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2012 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(11)70383-7 ;PMID: 22469125 ;CODEN: LANCAO

Full text available

8
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Material Type:
Article
Add to My Research

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Annals of surgical oncology, 2018-09, Vol.25 (9), p.2596-2602 [Peer Reviewed Journal]

Society of Surgical Oncology 2018 ;Annals of Surgical Oncology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-018-6637-9 ;PMID: 29978369

Full text available

9
Treatments for breast cancer in men: late effects and impact on quality of life
Material Type:
Article
Add to My Research

Treatments for breast cancer in men: late effects and impact on quality of life

Breast cancer research and treatment, 2023-10, Vol.201 (3), p.489-498 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-023-07027-6 ;PMID: 37418032

Digital Resources/Online E-Resources

10
Prognostic factors in male breast cancer: a population-based study
Material Type:
Article
Add to My Research

Prognostic factors in male breast cancer: a population-based study

Breast cancer research and treatment, 2016-04, Vol.156 (3), p.539-548 [Peer Reviewed Journal]

Springer Science+Business Media New York 2016 ;COPYRIGHT 2016 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-3768-1 ;PMID: 27039306 ;CODEN: BCTRD6

Full text available

11
The prognostic significance of tumour―stroma ratio in oestrogen receptor-positive breast cancer
Material Type:
Article
Add to My Research

The prognostic significance of tumour―stroma ratio in oestrogen receptor-positive breast cancer

British journal of cancer, 2014-04, Vol.110 (7), p.1744-1747 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 1, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.69 ;PMID: 24548861 ;CODEN: BJCAAI

Full text available

12
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics
Material Type:
Article
Add to My Research

Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics

PloS one, 2022-02, Vol.17 (2), p.e0264637-e0264637 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Nelson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Nelson et al 2022 Nelson et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0264637 ;PMID: 35213669

Full text available

13
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis
Material Type:
Article
Add to My Research

Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis

BMC cancer, 2016-07, Vol.16 (1), p.375-375, Article 375 [Peer Reviewed Journal]

COPYRIGHT 2016 BioMed Central Ltd. ;COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;The Author(s). 2016 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-016-2414-y ;PMID: 27377827

Full text available

14
Cytoplasmic DDX3 as prognosticator in male breast cancer
Material Type:
Article
Add to My Research

Cytoplasmic DDX3 as prognosticator in male breast cancer

Virchows Archiv : an international journal of pathology, 2021-10, Vol.479 (4), p.647-655 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0945-6317 ;EISSN: 1432-2307 ;DOI: 10.1007/s00428-021-03107-4 ;PMID: 33974127

Full text available

15
Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations
Material Type:
Article
Add to My Research

Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations

Journal of cancer research and clinical oncology, 2022-02, Vol.148 (2), p.441-447 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-021-03623-5 ;PMID: 33991247

Full text available

16
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
Material Type:
Article
Add to My Research

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

The lancet oncology, 2020-10, Vol.21 (10), p.1331-1340 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30456-3 ;PMID: 33002437

Full text available

17
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis
Material Type:
Article
Add to My Research

Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

British journal of cancer, 2019-02, Vol.120 (3), p.301-305 [Peer Reviewed Journal]

This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-018-0369-2 ;PMID: 30655614

Full text available

18
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
Material Type:
Article
Add to My Research

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

The lancet oncology, 2020-10, Vol.21 (10), p.1341-1352 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30454-X ;PMID: 33002438

Full text available

19
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
Material Type:
Article
Add to My Research

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface

British journal of cancer, 2014-01, Vol.110 (2), p.535-545 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Jan 21, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.730 ;PMID: 24346285 ;CODEN: BJCAAI

Full text available

20
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
Material Type:
Article
Add to My Research

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial

The lancet oncology, 2015-03, Vol.16 (3), p.274-283 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 2015 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70482-6 ;PMID: 25656287 ;CODEN: LANCAO

Full text available

Results 1 - 20 of 732,877  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1964  (107)
  2. 1964 To 1978  (26,176)
  3. 1979 To 1993  (81,147)
  4. 1994 To 2009  (228,196)
  5. After 2009  (397,587)
  6. More options open sub menu

Subject 

  1. Humans  (732,474)
  2. Male  (732,375)
  3. Female  (656,617)
  4. Science & Technology  (635,627)
  5. Middle Aged  (616,557)
  6. Life Sciences & Biomedicine  (600,298)
  7. Adult  (442,299)
  8. Aged, 80 And Over  (239,797)
  9. Biological And Medical Sciences  (191,810)
  10. Medical Sciences  (184,383)
  11. Adolescent  (146,164)
  12. Retrospective Studies  (114,409)
  13. Medicine  (108,605)
  14. Risk Factors  (108,509)
  15. Young Adult  (103,692)
  16. Surgery  (97,233)
  17. Treatment Outcome  (95,572)
  18. Medicine & Public Health  (90,067)
  19. Patients  (86,434)
  20. More options open sub menu

Language 

  1. English  (725,345)
  2. Japanese  (100,012)
  3. Portuguese  (2,681)
  4. German  (2,518)
  5. French  (1,781)
  6. Polish  (1,670)
  7. Spanish  (825)
  8. Italian  (820)
  9. Chinese  (749)
  10. Turkish  (507)
  11. Norwegian  (360)
  12. Lithuanian  (323)
  13. Russian  (149)
  14. Persian  (73)
  15. Croatian  (44)
  16. Dutch  (39)
  17. Afrikaans  (20)
  18. Swedish  (14)
  19. Finnish  (9)
  20. Arabic  (5)
  21. More options open sub menu

Searching Remote Databases, Please Wait